Skip to content

InnovAge Holdings, Inc. INNV Cash & Equivalents

Cash & Equivalents at other companies

Humana logo
HumanaHUM
$4.95B+16.5%
CVS Health logo
CVS HealthCVS
$9.77B-5.6%
UnitedHealth Group logo
UnitedHealth GroupUNH
$28B-8.8%
Astrana Health logo
Astrana HealthASTH
$478.38M+85.0%
Agilon Health logo
Agilon HealthAGL
$211.57M+52.6%
Aveanna Healthcare Holdings Inc. logo
Aveanna Healthcare Holdings Inc.AVAH
$189.27M+165%

Other financials

Income statement

See full
Revenue$251.9M+15.5%
Operating income-$29.1M-186%
Net income-$29.5M-159%
EPS (diluted)-$0.22-175%

Balance sheet

See full
Total debt$93.8M-11.0%
Total equity$229.0M-3.8%
Total assets$547.4M+2.0%

Cash flow

See full
Operating cash flow$18.1M-26.3%
CapEx$3.6M+24.3%
Free cash flow$14.5M-33.1%

Valuation

See full
Market cap$1.31B+170%
Enterprise value$1.31B+143%
P/S1.4×+0.8×

Profitability

See full
Operating margin-1%-0.4pp
Net margin-1.2%-0.5pp
FCF margin4.5%+2.6pp

Returns & leverage

See full
Return on equity-5%-1.8pp
Debt / equity0.4×0.0×
Current ratio+0.3×

Where this comes from

Reported directly by InnovAge Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.

The official record: InnovAge Holdings, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about InnovAge Holdings, Inc.'s cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is InnovAge Holdings, Inc.'s cash & equivalents?
InnovAge Holdings, Inc. (INNV) reported cash & equivalents of $95.55M in Q1 2026.
How has InnovAge Holdings, Inc.'s cash & equivalents changed year-over-year?
InnovAge Holdings, Inc.'s cash & equivalents increased by 58.0% year-over-year, from $60.47M to $95.55M.
What is the long-term trend for InnovAge Holdings, Inc.'s cash & equivalents?
Over 4 years (2021 to 2025), InnovAge Holdings, Inc.'s cash & equivalents has grown at a -25.1% compound annual growth rate (CAGR), from $203.7M to $64.14M.
What does cash & equivalents mean?
Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.